Companies researching Vaxzevria
Vaxzevria, previously known as the AstraZeneca COVID‑19 vaccine, is a pharmaceutical vaccine that reduces the risk of COVID‑19 infection in adults by using a modified adenovirus vector that carries the SARS‑CoV‑2 spike‑protein gene.
1
companies
List of companies that research Vaxzevria
This is sourced from job postings — companies only hire for what they actively use or plan to adopt · how we source this →

Employees23kRevenue$171MHigher Education
VaxzevriaLow confidence
Showing top companies out of 1 that research Vaxzevria. Get the full list on TheirStack.
Frequently asked questions